Abstract
Gold nanoparticles may be used in different domains, one of most important being the biomedical field. They have suitable properties for controlled drug delivery, cancer treatment, biomedical imaging, diagnosis and many others, due to their excellent compatibility with the human organism, low toxicity and tunable stability, small dimensions, and possibility to interact with a variety of substances. They also have optical properties, being able to absorb infrared light. Moreover, due to their large surface and the ability of being coated with a variety of therapeutic agents, gold nanoparticles have been showed a great potential to be used as drug delivery systems. Gold nanoparticles are intensively studied in biomedicine, and recent studies revealed the fact that they can cross the blood-brain barrier, may interact with the DNA and produce genotoxic effects. Because of their ability of producing heat, they can target and kill the tumors, being used very often in photodynamic therapy. Gold nanoparticles can be synthesized in many ways, but the most common are the biological and chemical methods, however the chemical method offers the advantage of better controlling the size and shape of the nanoparticles. In this review, we present the principal applications of gold nanoparticles in the biomedical field, like cancer treatment, amyloid-like fibrillogenesis inhibitors, transplacental treatment, the development of specific scaffolds and drug delivery systems.
Keywords: Gold nanoparticles, Biomedical applications, Nanomedicine, Bioimaging, Targeting, Delivery, Biocompatibility.
Current Topics in Medicinal Chemistry
Title:Biomedical Applications of Gold Nanoparticles
Volume: 15 Issue: 16
Author(s): Daniela Cabuzu, Andreea Cirja, Rebecca Puiu and Alexandru Mihai Grumezescu
Affiliation:
Keywords: Gold nanoparticles, Biomedical applications, Nanomedicine, Bioimaging, Targeting, Delivery, Biocompatibility.
Abstract: Gold nanoparticles may be used in different domains, one of most important being the biomedical field. They have suitable properties for controlled drug delivery, cancer treatment, biomedical imaging, diagnosis and many others, due to their excellent compatibility with the human organism, low toxicity and tunable stability, small dimensions, and possibility to interact with a variety of substances. They also have optical properties, being able to absorb infrared light. Moreover, due to their large surface and the ability of being coated with a variety of therapeutic agents, gold nanoparticles have been showed a great potential to be used as drug delivery systems. Gold nanoparticles are intensively studied in biomedicine, and recent studies revealed the fact that they can cross the blood-brain barrier, may interact with the DNA and produce genotoxic effects. Because of their ability of producing heat, they can target and kill the tumors, being used very often in photodynamic therapy. Gold nanoparticles can be synthesized in many ways, but the most common are the biological and chemical methods, however the chemical method offers the advantage of better controlling the size and shape of the nanoparticles. In this review, we present the principal applications of gold nanoparticles in the biomedical field, like cancer treatment, amyloid-like fibrillogenesis inhibitors, transplacental treatment, the development of specific scaffolds and drug delivery systems.
Export Options
About this article
Cite this article as:
Cabuzu Daniela, Cirja Andreea, Puiu Rebecca and Grumezescu Mihai Alexandru, Biomedical Applications of Gold Nanoparticles, Current Topics in Medicinal Chemistry 2015; 15 (16) . https://dx.doi.org/10.2174/1568026615666150414144750
DOI https://dx.doi.org/10.2174/1568026615666150414144750 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Epigenetic Factors that Drive Cancer Drug Resistance
Current Cancer Drug Targets Application of Decoy Oligodeoxynucleotides-Based Approach to Renal Diseases
Current Drug Targets PET/CT Based Dose Planning in Radiotherapy
Current Medical Imaging Structural Effects of TiO2 Nanoparticles and Doxorubicin on DNA and their Antiproliferative Roles in T47D and MCF7 Cells
Anti-Cancer Agents in Medicinal Chemistry Environmental Chemicals and Breast Cancer Risk – A Structural Chemistry Perspective
Current Medicinal Chemistry Thrombotic Microangiopathy and Occult Neoplasia
Cardiovascular & Hematological Disorders-Drug Targets Postmenopausal Health of Indian Women: A Review
Current Women`s Health Reviews Radiotracers in Oncology
Current Radiopharmaceuticals Artificial Intelligence Techniques for Colorectal Cancer Drug Metabolism: Ontologies and Complex Networks
Current Drug Metabolism Prediction and Early Evaluation of Anticancer Therapy Response: From Imaging of Drug Efflux Pumps to Targeted Therapy Response
Current Medicinal Chemistry The Role of TNF and Its Family Members in Inflammation and Cancer: Lessons from Gene Deletion
Current Drug Targets - Inflammation & Allergy HOXB7 and Hsa-miR-222 as the Potential Therapeutic Candidates for Metastatic Colorectal Cancer
Recent Patents on Anti-Cancer Drug Discovery Gallium-68: A New Trend in PET Radiopharmacy
Current Radiopharmaceuticals Editorial [Hot Topic:Non-Receptor Tyrosine Kinases as Molecular Targets for Patient Tailored Cancer Therapy (Guest Editors: F.M. Uckun, A. Vassilev and H. Tibbles)]
Anti-Cancer Agents in Medicinal Chemistry PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs
Current Pharmaceutical Design Nanotechnology: A Novel Approach for Drug Development in Health Care System
Current Nanomaterials Recent Progress in Chemically Modified siRNAs
Mini-Reviews in Medicinal Chemistry Dual Function of Nitric Oxide in Carcinogenesis, Reappraisal
Current Drug Metabolism Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Current Pharmaceutical Design Inflammatory Aspects of Depression
Inflammation & Allergy - Drug Targets (Discontinued)